REGNVSTMO• 28 Days (Normalized)
REGN vs TMO (Regeneron Pharmaceuticals Inc. vs Thermo Fisher Scientific Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
REGN Performance $739.57
-6.77%
Regeneron Pharmaceuticals Inc.
Normalized Baseline0.00%
TMO Performance $651.98
+8.09%
Thermo Fisher Scientific Inc.
Normalized Baseline0.00%
Alpha Spread Margin TMO LEADS
-14.86 pts
TMO outperforming by 14.86 percentage points
REGNTMO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
REGN TMO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | REGN Price | REGN Gain (%) | TMO Price | TMO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 08, 2026 | $739.57 | -6.77% | $651.98 | +8.09% | -14.86% |
| Oct 07, 2026 | $742.12 | -6.45% | $662.06 | +9.76% | -16.21% |
| Oct 06, 2026 | $738.72 | -6.88% | $656.58 | +8.85% | -15.73% |
| Oct 05, 2026 | $726.47 | -8.42% | $676.76 | +12.20% | -20.62% |
| Oct 02, 2026 | $735.20 | -7.32% | $654.80 | +8.56% | -15.88% |
| Sep 30, 2026 | $758.27 | -4.41% | $676.08 | +12.09% | -16.50% |
| Sep 29, 2026 | $750.51 | -5.39% | $679.61 | +12.67% | -18.06% |
| Sep 28, 2026 | $752.25 | -5.17% | $678.60 | +12.50% | -17.67% |
| Sep 25, 2026 | $788.04 | -0.66% | $675.00 | +11.91% | -12.57% |
| Sep 24, 2026 | $796.02 | +0.35% | $678.39 | +12.47% | -12.12% |
| Sep 23, 2026 | $801.82 | +1.08% | $665.30 | +10.30% | -9.22% |
| Sep 22, 2026 | $803.90 | +1.34% | $658.52 | +9.17% | -7.83% |
| Sep 21, 2026 | $798.17 | +0.62% | $658.76 | +9.21% | -8.59% |
| Sep 18, 2026 | $784.85 | -1.06% | $651.45 | +8.00% | -9.06% |
| Sep 17, 2026 | $789.45 | -0.48% | $658.32 | +9.14% | -9.62% |
Page 1 of 2